Addressing the unsolved challenges in microRNA-based biomarker development: Suitable endogenous reference microRNAs for SARS-CoV-2 infection severity
Open Access
- 28 April 2024
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 269 (Pt 2) , 131926
Abstract
No abstract availableKeywords
Funding Information
- Fundació la Marató de TV3
This publication has 45 references indexed in Scilit:
- Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive reviewReviews in Medical Virology, 2024
- MicroRNA-centered theranostics for pulmoprotection in critical COVID-19Molecular Therapy Nucleic Acids, 2024
- Identification of the viral and cellular microRNA interactomes during SARS-CoV-2 infectionCell Reports, 2023
- Challenges of microRNA‐based biomarkers in clinical application for cardiovascular diseasesClinical and Translational Medicine, 2022
- Reliable miRNA biomarker quantification in clinical practice – are we there yet?Analytical Biochemistry, 2021
- Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patientsTranslational Research, 2021
- miR-320c Regulates SERPINA1 Expression and Is Induced in Patients With Pulmonary DiseaseArchivos de Bronconeumología, 2021
- MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19Drugs, 2021
- Quantification of Circulating miRNAs in PlasmaThe Journal of Molecular Diagnostics, 2013
- Assessing sample and miRNA profile quality in serum and plasma or other biofluidsMethods, 2013